🇺🇬 Country Profile

Uganda

Affordable medicine reaching Uganda

🇺🇬 $127M
All data from DGCIS India export records (fiscal year, April–March).
$127M
Scale
Uganda's patients receive $127M in Indian pharmaceutical products annually, almost entirely finished medicines ready for dispensing.
78%
Medicine
Overwhelmingly finished medicines, drug formulations account for 78% of shipments.
Trajectory
India has maintained a consistent pharmaceutical supply to Uganda over the decade.
Context
Part of India's pharmaceutical supply network across Africa.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Uganda, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $99.1M (78.0%) Vaccines $16.9M (13.3%) Medicine Ingredients $8.5M (6.7%) Surgical & Hospital Supplies $1.9M (1.5%) Traditional & Herbal $0.59M (0.5%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Uganda Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Uganda: $2.2M across 18 filings (2019-2026).